Canada Tackles Pricing Review Backlog With New Interim Guidance

 
• By Francesca Bruce

Canada’s Patented Medicine Prices Review Board is consulting on further draft interim guidance on pricing to expedite reviews of medicines authorized since July 2022.

Canadian Money
Canada takes aim at pricing review backlog • Source: Shutterstock

More from Canada

More from North America